Blog - Page 10 of 5745 - QualityStocks

TuesdaySep 15, 2026 12:42 pm

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Reports Hotter, Denser Plasma in Latest Texatron(TM) Fusion-Energy Experiments

American Fusion (OTC: AMFN), a developer of advanced fusion-energy technology, announced results from its latest series of experiments involving its proprietary Texatron(TM) fusion-energy technology, reporting that a new high-voltage pulsed magnetic-field configuration produced toroidal plasmas that were hotter and denser than those generated in earlier high-current experiments while remaining stable against significant magnetohydrodynamic instabilities during the experimental pulse. The company said the observations support key elements of the Texatron(TM) concept, which uses rapid magnetic compression and shock heating in a pulsed approach to fusion, and plans further testing focused on quantitative measurements of plasma temperature, density, magnetic-field strength, compression behavior, confinement time and…

TuesdaySep 15, 2026 12:29 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company developing treatments for neurodegenerative and metabolic disorders and alcohol misuse disorders, announced its participation in the 3rd Annual ArcStone-Kingswood Growth Summit on Sept. 16, 2026, in Toronto, where Co-founder and Executive Co-chairman Anthony Durkacz will present the company’s recent milestones and future growth strategy. Quantum BioPharma recently announced that the U.S. Food and Drug Administration approved its Investigational New Drug application for Lucid-MS, allowing the company to begin Phase 2 trials of its patented, first-in-class multiple sclerosis program in patients with progressive MS. To…

TuesdaySep 15, 2026 11:55 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on GPS-Independent Drone Positioning

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced its placement in an AINewsWire editorial examining emerging positioning infrastructure designed to enable autonomous drones to operate when satellite navigation is unavailable or unreliable. The editorial highlights SPARC AI’s Overwatch Positioning Network, which uses a drone’s existing telemetry to calculate and return latitude, longitude and time from the company’s servers in roughly one-third of a second without requiring additional sensors, hardware or payload on the aircraft. To view the full press release, visit https://ibn.fm/u9eDv About…

TuesdaySep 15, 2026 11:44 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Appoints Rauni Malhi to Board of Directors

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced the appointment of Rauni Malhi as a director effective Sept. 15, 2026, following the resignation of Michael Kelly effective Sept. 7. Malhi, a British Columbia-based paralegal, has served on the boards of several TSX Venture Exchange-listed issuers, including Cairo Resources, which was rebranded as Gladiator Metals Corp. (TSXV: GLAD). LaFleur also granted Malhi 500,000 incentive stock options exercisable at $0.40 per share through Sept. 15, 2031, with half vesting immediately and the remainder vesting six months from the grant date. To view the full press…

TuesdaySep 15, 2026 11:36 am

QualityStocksNewsBreaks – BOXABL Inc. (NASDAQ: BXBL) Strengthens Finance Leadership With CFO, Chief Accounting Officer Appointments

BOXABL (NASDAQ: BXBL), a leader in innovative, factory-built modular solutions, announced the appointment of Larry King, CPA, as chief financial officer and Heather Clayton as chief accounting officer, strengthening its finance leadership as it builds out the infrastructure of a newly public company. King brings more than 35 years of finance, accounting and operations experience, including extensive SEC reporting, mergers and acquisitions and operational turnaround work, with prior senior roles at Chukchansi Gold Resort & Casino, Riviera Holdings Corp. and Tropicana Entertainment. Clayton brings nearly a decade of experience building and scaling finance and accounting functions for fast-growing, multi-entity organizations, including six years with the Vegas Golden…

TuesdaySep 15, 2026 10:30 am

Market Street Capital Inc. Sees Rising Power Demand Driving New Capital Choices for Founders

Energy is one of the sectors where the debt vs. equity decision has become especially pressing. As Market Street frames it, the tradeoff is straightforward in concept but consequential in practice. This is the kind of decision Market Street Capital's platform is built to help energy founders work through. For a growing number of middle-market energy founders, the hardest strategic decision is not what to build next but how to pay for it. Market Street Capital, a capital markets and financial advisory firm, works with established middle-market businesses navigating exactly this kind of decision. The company’s team members have spent…

TuesdaySep 15, 2026 9:45 am

BOXABL Inc. (NASDAQ: BXBL) Joins Nasdaq Following SPAC Merger Approval, Bringing Factory-Built Housing Model to Public Markets

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL has begun trading on Nasdaq under the ticker symbol BXBL. The move values BOXABL at approximately $3.5 billion, with approximately 350 million shares issued at $10 per share. The company has so far raised over $230 million from 50,000+ investors. BOXABL is pursuing a technology-driven approach…

TuesdaySep 15, 2026 9:45 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Reports Best Natural Hydrogen Readings to Date at Lawson Discovery

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) provided an exploration and operational update from its Lawson Natural Hydrogen Discovery in south-central Saskatchewan, reporting its highest Natural Hydrogen readings to date. Lawson 4 intersected a highly prospective 20.5-metre interval with evidence of strong permeability and porosity in the basal Cambrian Sandstone immediately above the Precambrian basement complex and a deep crustal fault. The company recovered 51.4 metres of core across the sandstone and underlying basement, with very elevated Natural Hydrogen readings and favorable…

TuesdaySep 15, 2026 9:10 am

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Reports Encouraging Gold, Silver Results From Santa Fe Heap Leach Pad

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced additional results from its 2026 Sonic core drilling program at the Santa Fe Mine Project in Nevada, reporting 10 holes totaling 168.9 metres from historic Heap Leach Pad Two, with nearly every 0.76-metre drill interval containing meaningful gold and silver mineralization. Based on the first 10 of 26 completed holes at HLP Two, all samples returned a weighted average grade of 0.50 g/t gold and 3.3 g/t silver, or 0.54 g/t gold equivalent, compared with an estimated…

TuesdaySep 15, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

VERAXA is developing antibody-based cancer therapies aimed at improving the therapeutic window of existing treatment modalities. Its proprietary BiTAC platform uses two complementary molecules that are designed to activate cytotoxic activity only when both recognize targets on the same tumor cell. The company is applying the BiTAC concept to both antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), with an emphasis on solid tumors. With ADCs and bispecific antibodies attracting substantial investment, VERAXA is operating in oncology markets where technological differentiation can have significant strategic value. VERAXA Biotech (NASDAQ: VRXA) is developing a new generation of antibody-based cancer therapies at a…

Site Search

Company Search